Needle-Free Vaccine Startup Appoints Former Merck Executive as CEO

Exciting news in the world of needle-free vaccines! Australian biotech company Vaxxas has brought on board global biopharmaceutical executive David Peacock as its new CEO. This move comes nine months after the departure of the former chief executive.

David Peacock, who hails from Brisbane but has spent 25 years at US pharmaceutical giant Merck & Co., is set to lead Vaxxas in bringing their innovative needle-free vaccine patches to market.

It’s always inspiring to see leaders with such impressive backgrounds joining forces to drive innovation and progress in the medical field. With Peacock’s expertise and Vaxxas’ cutting-edge technology, the future looks bright for the development of needle-free vaccines.

Stay tuned for more updates on this exciting partnership and the future of needle-free vaccination technology!